Related Experiment Video

Updated: May 25, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export

Kirsty M Brodie1, Beric R Henderson

  • 1Westmead Institute for Cancer Research, University of Sydney, Darcy Road (P.O. Box 412), Westmead, New South Wales 2145, Australia.

The Journal of Biological Chemistry
|January 21, 2012
PubMed

Insights

Researchers uncovered how BRCA1 protein targets centrosomes to prevent cancer cell division errors. Nuclear export receptor CRM1 and BARD1 regulate BRCA1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • BRCA1 protein is crucial for DNA damage response, acting in the nucleus for DNA repair and at the centrosome to prevent overduplication.
  • Loss or mutation of BRCA1 leads to centrosome amplification and abnormal mitotic spindle assembly in breast cancer cells.
  • The BRCA1-BARD1 heterodimer ubiquitinates γ-tubulin to inhibit centrosome amplification, but BRCA1's centrosomal regulation remains unclear.

Purpose of the Study:

  • To investigate the mechanisms regulating BRCA1's targeting and function at the centrosome.
  • To elucidate the roles of CRM1, BARD1, and Aurora A in BRCA1 centrosomal localization and activity.

Main Methods:

  • Utilized photobleaching experiments to analyze BRCA1 dynamics at the centrosome.
  • Investigated the impact of mutations in BRCA1's BRCT domain on centrosomal localization.
  • Examined the interaction between BRCA1, BARD1, CRM1, and Aurora A using cell-based assays.

Main Results:

  • Both N and C termini of BRCA1 are essential for centrosomal localization; BRCT domain mutations abolish this.
  • BRCA1 moves to the centrosome independently of BARD1 and γ-tubulin, with dynamic and immobilized pools regulated by CRM1 and BARD1.
  • CRM1 mediates BRCA1 nuclear export, and its interaction with undimerized BRCA1 facilitates centrosomal targeting, with BARD1 displacing CRM1 and reducing retention.

Conclusions:

  • CRM1, BARD1, and Aurora A collaboratively regulate BRCA1's targeting and function at the centrosome.
  • CRM1 facilitates BRCA1's transport to the centrosome, while BARD1 binding promotes its release, creating a regulated cycle.
  • Aurora A binding and phosphorylation enhance BRCA1's centrosomal retention and its role in regulating centrosome amplification.

More Related Videos

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins05:35

Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins

Published on: March 3, 2016

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Nuclear Export01:42

Nuclear Export

The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...